Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer-Reference-Cited by-同舟云学术

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

Published:2018-09-06 Issue:4 Volume:111 Page:409-418
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Jiang Hua¹,Shi Zhimin²,Wang Peng²,Wang Cong²,Yang Linlin²,Du Guoxiu²,Zhang Honghong²,Shi Bizhi¹,Jia Jie²,Li Qixiang³,Wang Huamao²,Li Zonghai¹²

Affiliation:

1. State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

2. CARsgen Therapeutics, Shanghai, China

3. Crown Bioscience, Inc, Santa Clara, CA

Funder

Shanghai Subject Chief Scientist

Shanghai Municipal Commission of Health and Family Planning

State Key Laboratory of Oncogenes and Related Genes

Renji Hospital

Shanghai Science and Technology Innovation Action Plan

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/111/4/409/28279468/djy134.pdf

Reference22 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

3. Regression of glioblastoma after chimeric antigen receptor T-cell therapy;Brown;N Engl J Med,2016

4. HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial;Ahmed;JAMA Oncol,2017

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy;Pathology - Research and Practice;2024-10

2. Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics;Targeted Oncology;2024-09-13

3. Targeting endothelial cell anergy to improve CAR T cell therapy for solid tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. CMG901, a Claudin18.2-specific antibody-drug conjugate, for the treatment of solid tumors;Cell Reports Medicine;2024-09

5. Clinical significance of peripheral blood immune cells in patients with gastric cancer after surgery;World Journal of Gastrointestinal Surgery;2024-08-27